Navigation Links
Vaccine provides 100 percent protection against avian flu virus in animal study

Scientists have sequenced and compared the genomes of planktonic microbes living throughout the water column in the Pacific Ocean. The pioneering study yielded insight into the specialization of microbial communities at each depth--ranging from 40 to more than 13,000 feet.

"By reading the information stored in the genomes of entire microbial communities, we can begin to measure the pulse of this marine ecosystem," said MIT's Ed DeLong, who led the research team. "These new DNA sequences from microbial communities will help us paint the picture of how that world works and provide important details on the players involved and their biological properties and activities."

DeLong and his coworkers report their findings in the Jan. 27 issue of the journal Science.

The interdisciplinary research team sequenced a total of 64 million base pairs, or subunits, of DNA from microbes and viruses they collected at each depth. In the process, they discovered thousands of new genes from novel and ecologically abundant microbes and found evidence of frequent gene exchange between organisms. The study also revealed variations in genetic composition at different depths--including differences among genes involved with carbon and energy metabolism.

"Although they're small, these tiny microbial species are the engines of the biosphere, and in large part drive the cycles of matter and energy in the sea," said DeLong.

Microbes near the ocean surface, for example, had more genes devoted to taking in iron, a major element necessary for growth in that zone. Genomes from organisms below the ocean's deepest and darkest layers displayed almost epidemic levels of DNA associated with "jumping genes," or pieces of DNA that can move from one part of the genome to another.

Microbial ecologists have had fairly rudimentary tools and techniques to bring to bear on their research to date, DeLong said. But now with the ability to sequence vast amounts of DNA i
'"/>

Source:University of Pittsburgh Medical Center


Page: 1 2 3

Related biology news :

1. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
2. Live Recombinant Adenovirus Vaccine Technique Explored
3. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
4. NIAID Initiates Trial of Experimental Avian Flu Vaccine
5. Study Models Impact Of Anthrax Vaccine
6. New Insights Into HIV Immunity Suggest Alternative Approach to Vaccines
7. Pathogen-Mimicking Vaccine As Strategy For Cancer Therapy
8. EuroVacc 02 HIV Vaccine Trial Begins
9. Active Vaccine Prevents Mice From Developing Prion Disease
10. New Vaccine To Be Used For First Time In Polio Outbreak Response
11. Boosting The BCG Vaccine To Beat Tuberculosis

Post Your Comments:
(Date:11/24/2009)...9) -- The Wildlife Conservation Society (WCS) anno...ning population of Siberian tigers has likely decl...ing and habitat loss. , WCS says the... needs to be done to protect remaining populations...report was released by the Siberian Tiger Monitori...
(Date:11/23/2009)...dence that the "synergistic" effect of early-life ... and indoor endotoxin causes more harm to developi..., Environmental health scientists at the Universi...wn that children exposed to both high levels of tr...g early life are six times more likely to experien...
(Date:11/23/2009)...ts gathered this week for the seventh annual Natio...This year,s topic, "Synthetic Biology," brought to...ers to explore the engineering, scientific, and so...hetic biology. , Bonnie L. Bassler, professor of...s year,s conference chair, challenged the attendee...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 1MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 2MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 3MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 4MTVs Season Finale of 16 26 Pregnant Hit Series Highs Among Both P12 34 281 9 29 and Total Viewers 282 1 Million 29 Thursday Ranking as the Number 52155 5OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 1OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 2OncoGenex Pharmaceuticals to Raise 249 5 Million Through Sale of Common Stock 13100 3TorreyPines Receives Notice of Delisting from Nasdaq Global Market 13095 1TorreyPines Receives Notice of Delisting from Nasdaq Global Market 13095 2
... Whether or not a fertilized mammalian egg ultimat...y the winner of a tug of war between two different...nt pathways they control, according to a new study...ists. , In their experiments in mice, the research...are in equal balance in the early stages of develo...
... A gene that is associated with osteoarthritis and...be responsible for preventing the onset of osteoar... led by Rhode Island Hospital. The matrilin-3 gene...bone mineral density in adulthood and prevents ost...in-3 have previously been linked to certain skelet...
... Most women at high risk for breast cancer do not ...tamoxifen, according to a new analysis by research...rgh and McMaster University in Ontario, Canada. In...s an extraordinarily expensive cancer-prevention s...of life saved. The study will be published in the ...
Other Biology News:Genetic tug of war determines sexual differentiation 2Genetic tug of war determines sexual differentiation 3Matrilin-3 gene discovered to prevent onset of osteoarthritis 2Matrilin-3 gene discovered to prevent onset of osteoarthritis 3Tamoxifen for breast cancer prevention does not benefit most women 2Tamoxifen for breast cancer prevention does not benefit most women 3
(Date:11/24/2009)...all/--IES(Nasdaq: IESC ),aleadingnationalprovidero...hecommercial,industrialandresidentialmarkets,annou...dedacontractfromManhattanTorconJVtoinstalltheelect...ementfacilityattheU.S.ArmyMedicalResearchInstitute...rick,Md. ,, ThenewUSAMRIIDreplacementfacilitywi...
(Date:11/24/2009)...ewswire-FirstCall/--deCODE,genetics,Inc.(Nasdaq: D...NasdaqStockMarketthattradinginthecompany,scommonst...SEwillbefiledwiththe,SecuritiesandExchangeCommissi...nNasdaq,unlessthecompanyfilesanappealtotheNasdaq,L...appeal,which,willstaythesuspensionanddelistingthro...
(Date:11/24/2009)...e-FirstCall/--NeurogesX,Inc.(Nasdaq: NGSX ),abioph...lizingnovelpainmanagementtherapies,announcedtodayt...r,isscheduledtopresentatthe21stAnnualPiperJaffrayH...ewYorkPalaceHotelinNewYork,NewYork. ,, Mr.DiTon...availabletorespondtoquestionsduringthepresentation...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-...ofadvancedlasersystemsandinstrumentsforthestemcell...rationalandfinancialresultsforthethirdquarterended...s$1.46millioncomparedwith$1.43millioninQ32008,-Gro...tinQ3,2008,-Netlossreducedto$148,000comparedto$283...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
...igma-Aldrich Corporation,(Nasdaq: SIAL ), will ho...,quarter results on Wednesday, July 23, 2008, at 1...his call is being webcast by Thomson/CCBN and can .../www.sigma-aldrich.com ., The webcast is also be...etwork to both institutional and individual invest...
... Following First-in-Man study success, Ovalum...™ technology in the coronary arteries. Ovalu...mpany, has announced today successful experiences ...aversing chronic total occlusions in the coronary ...ael (PRWEB) July 11, 2008 -- Following First-in-Ma...
...ewswire-FirstCall/ - ARIUS Research Inc., (TSX:,AR...ping the next wave of,antibody therapeutics, today...or the second fiscal quarter of 2008, ended May 31...ntained our focus on moving,ARIUS, anti-cancer ant...,our lead drug candidates received significant att...
Other Biology Technology:Sigma-Aldrich Corporation's 2nd Quarter 2008 Earnings Conference Call 2Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire 2ARIUS announces second quarter fiscal 2008 financial results 2ARIUS announces second quarter fiscal 2008 financial results 3ARIUS announces second quarter fiscal 2008 financial results 4ARIUS announces second quarter fiscal 2008 financial results 5ARIUS announces second quarter fiscal 2008 financial results 6ARIUS announces second quarter fiscal 2008 financial results 7ARIUS announces second quarter fiscal 2008 financial results 8ARIUS announces second quarter fiscal 2008 financial results 9ARIUS announces second quarter fiscal 2008 financial results 10ARIUS announces second quarter fiscal 2008 financial results 11ARIUS announces second quarter fiscal 2008 financial results 12ARIUS announces second quarter fiscal 2008 financial results 13ARIUS announces second quarter fiscal 2008 financial results 14ARIUS announces second quarter fiscal 2008 financial results 15
Cytological Nuclear Counterstain Kit - DAPI/SYTOX Green/PI - 300 slides from Molecular Probes (Invitrogen)
Goat Anti-Human SorCS1 Polyclonal Antibody, Unconjugated from R&D Systems
Goat Anti-Human PLUNC Polyclonal Antibody, Biotin Conjugated from R&D Systems
Mouse Anti-Human RXR beta / NR2B2 Monoclonal Antibody, Unconjugated, Clone H7341 from R&D Systems
Biology Products: